SEARCH

SEARCH BY CITATION

References

  • 1
    Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97107.
  • 2
    O'Sullivan BG, Gidding HF, Law M, Kaldor JM, Gilbert GL, Dore GJ. Estimates of chronic hepatitis B virus infection in Australia, 2000. Aust NZ J Public Health. 2004;28(3):21216.
  • 3
    Amin J, Law MG, Bartlett M, Kaldor JM, Dore GJ. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study [see comment]. Lancet. 2006;368(9539):93845.
  • 4
    Robotin MC, George J, Supramaniam R, Sitas F, Penman AG. Preventing primary liver cancer: how well are we faring towards a national hepatitis B strategy Med J Aust. 2008;188(6):3635.
  • 5
    Coates M, Tracey E. Cancer in New South Wales: Incidence and mortality 1997. N S W Public Health Bull. 2001;12(2): 402.
  • 6
    Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 200; 130(7):41722.
  • 7
    Robotin MC, Kansil M, Howard K, George J, Tipper S, Dore GJ, et al. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening. J Hepatol. 2009;50(5):9908.
  • 8
    National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia: Annual Surveillance Report 2009 [report on the Internet]. Sydney ( AUST ) : National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales; 2009 [cited 2010 Jan 25]. Available from: http://www.nchecr.unsw.edu.au/NCHECRweb.nsf/resources/SurvReports_3/$file/ASR2009-updated-2.pdf.
  • 9
    Nightingdale S, Stormon M, Day A, Webber M, Ward K, O'Loughlin E. Chronic hepatitis B and C infection in children in New South Wales. Med J Aust. 2009;190(12):6703.
  • 10
    Guirgis M, Zekry A, Yan K, Min Bu Y, Lee A. Chronic hepatitis B infection in an Australian antenatal population: seroprevalence and opportunities for better outcomes. J Gastroenterol Hepatol. 2009;24(6):9981001.
  • 11
    Weinbaum C, Williams I, Mast E, Wang S, Finelli L, Wasley A, et al. Recommendations for Identification and Public Health Management of persons with chronic hepatitis B. MMWR Morb Mortal Wkly Rep. 2008;57(RR08):120.
  • 12
    Department of Health and Ageing [homepage on the Internet]. Canberra ( AUST ) : Commonwealth of Australia; 2004 [cited August 2009]. Australian National Notifiable Diseases Case Definitions – Hepatitis B (unspecified). Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveil-nndss-casedefs-cd_hepbun.htm.
  • 13
    Australian Bureau of Statistics, Australia: Country of birth of Person by Sex, 2006. Canberra ( AUST ) : ABS; 2007. Catalogue No.: 2068.0.
  • 14
    Cowie B, Kelly H. Mapping hepatitis B at the crossroads: the correlation between seroprevalence, notifications and migration and predictions from a parsimonious linear regression model. J Gastroenterol Hepatol. 2008;23 Suppl 6:A343.
  • 15
    Yuen MF, Yuan HJ, Hui CK, Wong KH, Wong WM, Chan AOO, et al. A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy. Gut. 2003;52(3):4169.
  • 16
    Tawk HM, Vickery K, Bisset L, Lo SK, Selby W, Cossart YE. The current pattern of hepatitis B virus infection in Australia. J Viral Hepat. 2006;13(3):20615.
  • 17
    Williams SJ, Batey RG, Craig PI, Farrell GC, Liddle C. Hepatitis B in Australia: determinants of intrafamily spread. Aust N Z J Med. 1987;17(2):2207.
  • 18
    Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45(2):50739.
  • 19
    Weinberg MS, Gunn R, Mast E, Gresham L, Ginsberg M. Preventing transmission of hepatitis B virus from people with chronic infection. Am J Prev Med. 2001;20(4):2726.
  • 20
    Previsani N, Lavanchy D. Hepatitis B [monograph on the Internet] Geneva ( CHE ) : World Health Organization; 2002 [cited 2009 Aug 5]. Available from: http://www.who.int/csr/disease/hepatitis/HepatitisB_whocdscsrlyo2002_2.pdf.
  • 21
    Gilbert GL. Prevention of vertical transmission of hepatitis B. The place of routine screening in antenatal care, and the case for immunization of infants at risk. Med J Aust. 1984;141(4):2136.
  • 22
    Fielding J, editor. Surveillance of Notifiable Infectious Diseases in Victoria 2005. Melbourne ( AUST ) : Communicable Disease Control Unit, Public Health Branch, Department of Human Services Victoria; 2007.
  • 23
    Birbilis E, Moran R. Improving infectious disease notification rates: a medical practitioner survey. Victorian Infectious Diseases Bulletin. 2009;12(1):1214.
  • 24
    Miller M, Roche P, Spencer J, Deeble M. Evaluation of Australia's National Notifiable Disease Surveillance System. Commun Dis Intell. 2004;28(3):31123.
  • 25
    Australian Government Department of Health and Ageing. National Hepatitis B Strategy 2010 – 2013. Canberra ( AUST ) : Commonwealth of Australia; 2010.
  • 26
    Dore GJ, Wallace J, Locarnini S, Desmond P, Gane E, Crawfor, D. Hepatitis B in Australia: Responding to a Diverse Epidemic [monograph on the Internet]. Melbourne ( AUST ) : Advancing the Clinical Treatment of Hepatitis B Virus (ACT-HBV); 2006 [cited 2009 Aug 10]. Available from: http://www.ashm.org.au/uploads/Hep-B-in-Australia.pdf.